Relapsing Polychondritis in a Patient with Ankylosing Spondylitis under Two Different Tumor Necrosis Factor Alpha Inhibitors Treatment
Clinica Terapeutica, cilt.173, sa.2, ss.97-98, 2022 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 173 Sayı: 2
- Basım Tarihi: 2022
- Doi Numarası: 10.7417/ct.2022.2400
- Dergi Adı: Clinica Terapeutica
- Derginin Tarandığı İndeksler: Scopus, EMBASE, MEDLINE
- Sayfa Sayıları: ss.97-98
- Anahtar Kelimeler: adverse event, Polychondritis, TNF alpha inhibitor
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Relapsing polychondritis (RP) is a rare autoimmune disease characterized by multi-systemic involvement characterized by recurrent and progressive inflammation of the cartilaginous tissue. Auricular inflammation is a characteristic finding of RP. Anti-tumor necrosis factor alpha (anti-TNF) is a highly effective drug used in the treatment of inflammatory arthritis. There are several case reports showing potential relationship between the RP development and anti-TNF treatment. Here, we present a case of RP in a patient with ankylosing spondylitis under the two different tumor necrosis factor alpha inhibitors therapy.